{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:34:44Z","timestamp":1776875684876,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010590","name":"Tianjin Municipal Health Bureau","doi-asserted-by":"publisher","award":["No. 2010KZ61"],"award-info":[{"award-number":["No. 2010KZ61"]}],"id":[{"id":"10.13039\/501100010590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010590","name":"Tianjin Municipal Health Bureau","doi-asserted-by":"publisher","award":["No. 2013KR18"],"award-info":[{"award-number":["No. 2013KR18"]}],"id":[{"id":"10.13039\/501100010590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00380-018-01338-1","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T01:05:53Z","timestamp":1548291953000},"page":"1230-1239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of Telmisartan on the expression of connexin43 and neointimal hyperplasia in a rabbit iliac artery restenosis model"],"prefix":"10.1007","volume":"34","author":[{"given":"Lu","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianghui","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"key":"1338_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nrcardio.2011.132","volume":"9","author":"JW Jukema","year":"2011","unstructured":"Jukema JW, Verscuren JJ, Ahmed TA, Quax PH (2011) Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol 9:53\u201362","journal-title":"Nat Rev Cardiol"},{"key":"1338_CR2","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","volume":"63","author":"F Alfonso","year":"2014","unstructured":"Alfonso F, Byrne RA, Rivero F, Kastrati A (2014) Current treatment of in-stent restenosis. J Am Coll Cardiol 63:2659\u20132673","journal-title":"J Am Coll Cardiol"},{"key":"1338_CR3","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","volume":"36","author":"RA Byrne","year":"2015","unstructured":"Byrne RA, Joner M, Kastrati A (2015) Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig Lecture ESC 2014. Eur Heart J 36:3320\u20133331","journal-title":"Eur Heart J"},{"key":"1338_CR4","doi-asserted-by":"publisher","first-page":"E33","DOI":"10.3390\/jpm8040033","volume":"8","author":"J Canfield","year":"2018","unstructured":"Canfield J, Totary-Jain H (2018) 40 years of percutaneous coronary intervention: history and future directions. J Pers Med 8:E33","journal-title":"J Pers Med"},{"key":"1338_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/187152911795945169","volume":"11","author":"A Pourdjabbar","year":"2011","unstructured":"Pourdjabbar A, Hibbert B, Simard T, Ma X, O\u2019Brien E (2011) Pathogenesis of neointima formation following vascular injury. Cardiovasc Hematol Disord Drug Targets 11:30\u201339","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"1338_CR6","first-page":"1778","volume":"97","author":"ZJ Liu","year":"2017","unstructured":"Liu ZJ, Shi B, Deng CC, Xu GX, Zhao RZ, Chen CY, Wang ZL, Liu HL (2017) Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation. Natl Med J China 97:1778\u20131783","journal-title":"Natl Med J China"},{"key":"1338_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvt115","volume":"99","author":"C Chaabane","year":"2013","unstructured":"Chaabane C, Otsuka F, Virmani R, Bochaton-Piallat ML (2013) Biological responses in stented arteries. Cardiovasc Res 99:353\u2013363","journal-title":"Cardiovasc Res"},{"key":"1338_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/CIRCINTERVENTIONS.110.957332","volume":"4","author":"SO Marx","year":"2011","unstructured":"Marx SO, Totary-Jain H, Marks AR (2011) Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 4:104\u2013111","journal-title":"Circ Cardiovasc Interv"},{"key":"1338_CR9","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1161\/ATVBAHA.117.310051","volume":"37","author":"BJ Wu","year":"2017","unstructured":"Wu BJ, Li Y, Ong KL, Sun Y, Shrestha S, Hou L, Johns D, Barter PJ, Rye KA (2017) Reduction of in-stent restenosis by cholesteryl ester transfer protein inhibition. Arterioscler Thromb Vasc Biol 37:2333\u20132341","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1338_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK (2016) Vascular smooth muscle cells in atherosclerosis. Circ Res 118:692\u2013702","journal-title":"Circ Res"},{"key":"1338_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/ars.2008.2115","volume":"11","author":"AC Brisset","year":"2009","unstructured":"Brisset AC, Isakson BE, Kwak BR (2009) Connexins in vascular physiology and pathology. Antioxid Redox Signal 11:267\u2013282","journal-title":"Antioxid Redox Signal"},{"key":"1338_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-1-62703-505-7_22","volume":"1037","author":"S Morel","year":"2013","unstructured":"Morel S, Kwak BR (2013) Vascular connexins in restenosis after baloon injury. Methods Mol Biol 1037:381\u2013398","journal-title":"Methods Mol Biol"},{"key":"1338_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1124\/pr.115.012062","volume":"69","author":"L Leybaert","year":"2017","unstructured":"Leybaert L, Lampe PD, Dhein S, Kwak BR, Ferdinandy P, Beyer EC, Laird DW, Naus CC, Green CR, Schulz R (2017) Connexins in cardiovascular and neurovascular health and disease: pharmacological implications. Pharmacol Rev 69:396\u2013478","journal-title":"Pharmacol Rev"},{"key":"1338_CR14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1161\/01.RES.84.11.1277","volume":"84","author":"X Li","year":"1999","unstructured":"Li X, Simard JM (1999) Multiple connexins form gap junction channels in rat basilar artery smooth muscle cells. Circ Res 84:1277\u20131284","journal-title":"Circ Res"},{"key":"1338_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12860-016-0119-3","volume":"18","author":"D Begandt","year":"2017","unstructured":"Begandt D, Good ME, Keller AS, DeLalio LJ, Rowley C, Isakson BE, Figueroa XF (2017) Pannexin channel and connexin hemichannel expression in vascular function and inflammation. BMC Cell Biol 18:2","journal-title":"BMC Cell Biol"},{"key":"1338_CR16","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.3390\/ijms18112254","volume":"18","author":"T Okamoto","year":"2017","unstructured":"Okamoto T, Suzuki K (2017) The role of gap junction-mediated endothelial cell-cell interaction in the crosstalk between inflammation and blood coagulation. Int J Mol Sci 18:2254","journal-title":"Int J Mol Sci"},{"key":"1338_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jvs.2005.02.036","volume":"41","author":"S D\u00e9glise","year":"2005","unstructured":"D\u00e9glise S, Martin D, Probst H, Saucy F, Hayoz D, Waeber G, Nicod P, Ris HB, Corpataux JM, Haefliger JA (2005) Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia. J Vasc Surg 41:1043\u20131052","journal-title":"J Vasc Surg"},{"key":"1338_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3892\/ijmm.2015.2078","volume":"35","author":"XJ Han","year":"2015","unstructured":"Han XJ, Chen M, Hong T, Zhu LY, He D, Feng JG, Jiang LP (2015) Lentivirus-mediated RNAi knockdown of the gap junction protein, Cx43, attenuates the development of vascular restenosis following balloon injury. Int J Mol Med 35:885\u2013892","journal-title":"Int J Mol Med"},{"key":"1338_CR19","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3892\/ijmm.2015.2346","volume":"36","author":"XJ Han","year":"2015","unstructured":"Han XJ, He D, Xu LJ, Chen M, Wang YQ, Feng JG, Wei MJ, Hong T, Jiang LP (2015) Knockdown of connexin 43 attenuates balloon injury-induced vascular restenosis through the inhibition of the proliferation and migration of vascular smooth muscle cells. Int J Mol Med 36:1361\u20131368","journal-title":"Int J Mol Med"},{"key":"1338_CR20","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.3892\/mmr.2016.5783","volume":"14","author":"LJ Wang","year":"2016","unstructured":"Wang LJ, Liu WD, Zhang L, Ma KT, Zhao L, Shi WY, Zhang WW, Wang YZ, Li L, Si JQ (2016) Enhanced expression of Cx43 and gap junction communication in vascular smooth muscle cells of spontaneously hypertensive rats. Mol Med Rep 14:4083\u20134090","journal-title":"Mol Med Rep"},{"key":"1338_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yjmcc.2013.10.013","volume":"66","author":"T Bruder-Nascimento","year":"2014","unstructured":"Bruder-Nascimento T, Chinnasamy P, Riascos-Bernal DF, Cau SB, Callera GE, Touyz RM, Tostes RC, Sibinga NE (2014) Angiotensin II induces Fat1expresion\/activation and vascular smooth muscle cellmigration via Nox1dependent reactive oxygen species generation. J Mol Cell Cardiol 66:18\u201326","journal-title":"J Mol Cell Cardiol"},{"key":"1338_CR22","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.jacc.2015.04.041","volume":"65","author":"S Rinfret","year":"2015","unstructured":"Rinfret S, Baron SJ, Cohen DJ (2015) Percutaneous coronary intervention: finally mature enough. J Am Coll Cardiol 65:2508\u20132510","journal-title":"J Am Coll Cardiol"},{"key":"1338_CR23","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1161\/CIRCULATIONAHA.116.023551","volume":"133","author":"DP Faxon","year":"2016","unstructured":"Faxon DP, Williams DO (2016) Interventional cardiology: current status and future directions in coronary disease and valvular heart disease. Circulation 133:2697\u20132711","journal-title":"Circulation"},{"key":"1338_CR24","doi-asserted-by":"publisher","first-page":"E1150","DOI":"10.21037\/jtd.2016.10.93","volume":"8","author":"D Buccheri","year":"2016","unstructured":"Buccheri D, Piraino D, Andolina G, Cortese B (2016) Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis 8:E1150\u2013E1162","journal-title":"J Thorac Dis"},{"key":"1338_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/cvr\/cvy022","volume":"114","author":"S Allahverdian","year":"2018","unstructured":"Allahverdian S, Chaabane C, Boukais K, Francis GA, Bochaton-Piallat ML (2018) Smooth muscle cell fate and plasticity in atherosclerosis. Cardiovasc Res 114:540\u2013550","journal-title":"Cardiovasc Res"},{"key":"1338_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/apha.12466","volume":"214","author":"DA Chistiakov","year":"2015","unstructured":"Chistiakov DA, Orekhov AN, Bobryshev YV (2015) Vascular smooth muscle cell in atherosclerosis. Acta Physiol 214:33\u201350","journal-title":"Acta Physiol"},{"key":"1338_CR27","first-page":"406236","volume":"2012","author":"L Denes","year":"2012","unstructured":"Denes L, Entz L, Jancsika V (2012) Restenosis and therapy. Int J Vasc Med 2012:406236","journal-title":"Int J Vasc Med"},{"key":"1338_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/cvr\/cvs135","volume":"95","author":"P Lacolley","year":"2012","unstructured":"Lacolley P, Regnault V, Nicoletti A, Li Z, Michel JB (2012) The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 95:194\u2013204","journal-title":"Cardiovasc Res"},{"key":"1338_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0021-9150(96)05807-8","volume":"123","author":"S Nikol","year":"1996","unstructured":"Nikol S, Huehns TY, H\u00f6fling B (1996) Molecular biology and post-angioplasty restenosis. Atherosclerosis 123:17\u201331","journal-title":"Atherosclerosis"},{"key":"1338_CR30","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1161\/01.ATV.17.11.3174","volume":"17","author":"HI Yeh","year":"1997","unstructured":"Yeh HI, Lupu F, Dupont E, Severs NJ (1997) Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler Thromb Vasc Biol 17:3174\u20133184","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1338_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3892\/mmr.2016.5286","volume":"14","author":"XM Zhang","year":"2016","unstructured":"Zhang XM, Wang XD, Zhou XH, Ma XY, Yao Y, Liu XB (2016) Phenotypic transformation of smooth muscle cells from porcine coronary arteries is associated with connexin 43. Mol Med Rep 14:41\u201348","journal-title":"Mol Med Rep"},{"key":"1338_CR32","doi-asserted-by":"publisher","first-page":"e0137960","DOI":"10.1371\/journal.pone.0137960","volume":"10","author":"K Nagayama","year":"2015","unstructured":"Nagayama K, Kyotani Y, Zhao J, Ito S, Ozawa K, Bolstad FA, Yoshizumi M (2015) Exendin-4 prevents vascular smooth muscle cell proliferation and migration by angiotensin II via the Inhibition of ERK1\/2 and JNK signaling pathways. PLoS ONE 10:e0137960","journal-title":"PLoS ONE"},{"key":"1338_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/hr.2013.108","volume":"37","author":"G Liu","year":"2014","unstructured":"Liu G, Hitomi H, Rahman A, Nakano D, Mori H, Masaki T, Ma H, Iwamoto T, Kobori H, Nishiyama A (2014) High sodium augments angiotensin II-induced vascular smooth muscle cell proliferation through the ERK 1\/2-dependent pathway. Hypertens Res 37:13\u201318","journal-title":"Hypertens Res"},{"key":"1338_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11906-014-0431-2","volume":"16","author":"AC Montezano","year":"2014","unstructured":"Montezano AC, Nguyen Dinh Cat A, Rios FJ, Touyz RM (2014) Angiotensin II and vascular injury. Curr Hypertens Rep 16:431","journal-title":"Curr Hypertens Rep"},{"key":"1338_CR35","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.yjmcc.2008.03.002","volume":"44","author":"G Jia","year":"2008","unstructured":"Jia G, Cheng G, Gangahar DM, Agrawal DK (2008) Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway. J Mol Cell Cardiol 44:882\u2013890","journal-title":"J Mol Cell Cardiol"},{"key":"1338_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/cvr\/cvq031","volume":"87","author":"F Alonso","year":"2010","unstructured":"Alonso F, Krattinger N, Mazzloai L, Simon A, Waeber G, Meda P, Haefliger JA (2010) An angiotensionII-and NF-Kb-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension. Cardiovasc Res 87:166\u2013176","journal-title":"Cardiovasc Res"},{"key":"1338_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.yexmp.2015.11.013","volume":"99","author":"J Hou","year":"2015","unstructured":"Hou J, Yan P, Guo T, Xing Y, Zheng S, Zhou C, Huang H, Long H, Zhong T, Wu Q, Wang J, Wang T (2015) Cardiac stem cells transplantation enhances the expression of connexin 43 via the ANG II\/AT1R\/TGF-beta1 signaling pathway in a rat model of myocardial infarction. Exp Mol Pathol 99:693\u2013701","journal-title":"Exp Mol Pathol"},{"key":"1338_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijcard.2015.03.425","volume":"188","author":"C Liu","year":"2015","unstructured":"Liu C, Fan Y, Zhou L, Zhu HY, Song YC, Hu L, Wang Y, Li QP (2015) Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction. Int J Cardiol 188:22\u201332","journal-title":"Int J Cardiol"},{"key":"1338_CR39","first-page":"365","volume":"37","author":"AO Mueck","year":"1999","unstructured":"Mueck AO, Seeqer H, Lippert TH (1999) Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery. Int J Clin Pharmacol Ther 37:365\u2013366","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1338_CR40","first-page":"93","volume":"13","author":"S Peters","year":"2001","unstructured":"Peters S, G\u00f6tting B, Tr\u03cbmmel M, Rust H, Brattstr\u00f6m A (2001) Valsartan for prevention of restenosis after stenting of type B2\/C lesions: the VAL-PREST trial. J Invasive Cardiol 13:93\u201397","journal-title":"J Invasive Cardiol"},{"key":"1338_CR41","doi-asserted-by":"publisher","first-page":"H282","DOI":"10.1152\/ajpheart.00231.2012","volume":"303","author":"AJ Valente","year":"2012","unstructured":"Valente AJ, Yoshida T, Murthy SN, Sakamuri SS, Katsuyama M, Clark RA, Delafontaine P, Chandrasekar B (2012) Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. Am J Physiol Heart Circ Physiol 303:H282\u2013H296","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1338_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1179\/1743132814Y.0000000436","volume":"37","author":"N Ichikawa","year":"2015","unstructured":"Ichikawa N, Toma N, Kawakita F, Matsushima S, Imanaka-Yoshida K, Yoshida T, Taki W, Suzuki HI (2015) Angiotensin II type 1 receptor blockers suppress neointimal hyperplasia after stent implantation in carotid arteries of hypercholesterolemic rabbits. Neurol Res 37:147\u2013152","journal-title":"Neurol Res"},{"key":"1338_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12872-017-0709-9","volume":"17","author":"JY Cho","year":"2017","unstructured":"Cho JY, Hong SJ, Lim DS (2017) Effects of angiotensin receptor blockers on neointimal characteristics in angina patients requiring stent implantation: optical coherence tomography analysis. BMC Cardiovasc Disord 17:278","journal-title":"BMC Cardiovasc Disord"},{"key":"1338_CR44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2165\/11591780-000000000-00000","volume":"11","author":"X Kun","year":"2011","unstructured":"Kun X, Yong L, Bo J, Hai-Ming S (2011) Neointimal hyperplasia inhibition effect of angiotensin II type 1 receptor blockers in patients after coronary stent implantation: a meta-analysis. Am J Cardiovasc Drugs 11:209\u2013213","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-018-01338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-018-01338-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-018-01338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T20:31:23Z","timestamp":1579638683000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-018-01338-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1007\/s00380-018-01338-1","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}